Source Fact: Financial Supervisory Service DART / 2025-05-22
Disclosure Type: Suspension and Resumption of Trading for Stock Futures and Options
💡 3-Second Summary
Following the market action on the underlying asset of Samsung Biologics, the trading of its respective stock futures and options was temporarily suspended at 07:45 AM on May 22, 2025, and successfully resumed at 09:30 AM on the same day.
📊 1. [Key Disclosure Content & Summary of Major Figures]
- Subject Assets: Samsung Biologics Co., Ltd. Stock Futures & Stock Options
- Suspension Date & Time: May 22, 2025, at 07:45
- Resumption Date & Time: May 22, 2025, at 09:30
- Reason for Action: Imposed and lifted market suspension on the underlying asset
- Legal Basis: Article 74 of the Detailed Enforcement Rules of the Derivatives Market Business Regulations
📈 2. [Expert Insight: What This Disclosure Means for Investors]
This disclosure represents a procedural and temporary trading restriction within the derivatives market rather than a fundamental shift in the company’s long-term business performance. While the suspension took effect before the market opened at 07:45 AM, trading resumed shortly after the regular market opening at 09:30 AM, allowing investors holding derivatives positions to readjust or liquidate their contracts.
However, given the inherent characteristics of the derivatives market, the post-resumption period may see temporary widening of bid-ask spreads or elevated volatility. Investors could face short-term execution risks and should carefully monitor order book depth. Note that this disclosure does not specify the underlying reasons for the initial suspension or subsequent lifting of the restriction on the underlying cash equity.
📝 Editor’s Comment (by K-STOCK Editor)
Derivatives traders might have experienced a brief moment of anxiety due to the sudden suspension and subsequent resumption early in the morning. Fortunately, trading returned to normal at 09:30 AM. However, as the disclosure does not outline the exact cause behind the underlying stock’s trading halt, investors are advised to monitor the cash equity market closely. Rather than engaging in speculative trades based on rumors, a more prudent approach would be to wait for order book stability.
📢 Disclaimer & Source Information
Source: This content was structured and newly written based on the official data submitted to the Financial Supervisory Service electronic disclosure system (DART).
Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest solely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
